Previous investigators of this drug, notably Kuhn-in Switzerland, and in this country Lehmann", Azirna", and Mann-, and others have reported on its efficacy in different situations in the treatment of depressed persons. The purpose of this study is to evaluate the drug by the double blind method in the treatment of acute depressive states admitted to a clinic of psychological medicine. We wished to establish whether or not the drug has a specific effect over and above that of hospitalization and non-specific agents.
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Method
To carry out this study all patients admitted to the Crease Clinic of Psychological Medicine over a period of time and showing two or more of the following symptoms were entered on a project to investigate this drug. The symptoms were:
(1) Depression of Mood.
(2) Psychomotor Retardation or Agitation.
(3) Attitude of Hopelessness.
(4) Suicidal Act or Gesture. (5) Loss or Self-assertiveness.
(6) Loss of Self-esteem.
(7) Difficulty in making decisions.
Because it was our purpose to investigate primarily its efficacy in acute depressions all those patients who showed schizophrenic components, paranoid components, epilepsy or mental deficiency were excluded. In all 62 patients were referred to the project which consisted of a double blind experiment as noted above. Patients were started on 150 mg., of Imipramine per day and increased within one or two days to 200 mg. per day in divided doses. This dose was maintained for one month. Of the 62, 38 were given the active drug and 24 were given a placebo which outwardly appeared identical. Only one of the authors was aware whether the patients were getting the drug or the placebo. The clinical appraisals were done by the other two authors immediately before commencing the study and again at the end. These written reports were gone over and evaluated by a third person. The degree of correlation of improvement was very good. Patients on the project were rated by the Head Nurse on the ward by means of a Wittenborn Rating Scale.
The following psychological tests were also done:
(1) Tapping and Dotting. This is a motor task adapted from a test of mechanical ability which we believe might give some indication of the patients degree of motor retardation. The patient had to tap three times in a series of circles, or place dots in irregularly placed tiny circles.
(2) A test wherein the patient is asked to name words as quickly as he can beginning with a particular letter. We believed that this test would give us some idea of the patient's ability to bring forth old associations and his freedom from blocking. The number of words he could bring forth in thirty seconds was counted.°C rease Clinic of Psychological Medicine, Essondale, B.C., and University of British Columbia, Vancouver, B.C.
(3) The final test was the digit symbols sub test of the Wechsler Bellevue Adult Intelligence Scale, Form II. In this special test the patient must substitute symbols under numbers according to a code laid out. In this test we hoped to measure the patient's ability to learn new associations. Unfortunately we were not able to do psychological assessments on all of the patients who had clinical evaluations. However a total of 35 patients were assessed in this way.
Using the criteria for selection noted above the patients fell into the following diagnostic groupings.
(1) Psychoneurotic Depressive Reaction.
(2) Psychotic Depressive Reaction.
(3) Manic Depressive Psychosis -Depressed.
For the purpose of reporting we are dividing the group only in terms of Neurotic Depressive Reaction or Psychotic Depressive Reaction.
A further study was also done following the initial experiment to determine if those patients who had received the drug and had not responded well and later were given E.C.T. were sensitized in such a way that they required less electric shock to bring about improvement. This has been referred to as an electric shock sparing effect. Table I noted below it can be seen that out of the control group of 24 patients, 6 improved and 18 did not. Out of the drug treated group of 38 patients, 24 improved and 14 were unimproved. There is then an overall improvement rate of 60% in the drug treated group. This is generally lower than results reported by other investigators, notably Lehmann and Kuhn, who show a 75% improvement with Endogenous Depression, and Azima and Vispo who report 83.6% general improvement. However using the Chi Square Test in evaluating this improvement against our control this is considered a highly significant difference within the two groups at the 1% point of confidence. That is there is less than one possibility in One Hundred that such results could be obtained by chance alone. We believe this establishes the drug as an effective agent for the treatment of depressive syndromes over and above the possible effect of non-specific factors such as hospitalization, milieu, etc. As reported by other authors the Endogenous Retarded Depressions tend to respond the best. However, we found that some patients in this group showed virtually no improvement while similar cases on exactly the same medication and management showed some of the most remarkable results. We are not able to explain this observation. Of the six patients on placebo who improved, three of them obtained good results and this does indicate the fact that depression is a self-limiting disease and that purely hospital management itself or no treatment can lead to remission. In explaining our lower incidence of overall improvement we would like to point out that conducting a controlled study on an admission group of very depressed patients is a difficult task due to the seriousness of the illness in some patients. Accordingly where a doctor indicated that his patient was very sick the author may have been biased to give the drug to more patients who were very ill and the placebo to others when this was not indicated. This however would load the experiment against the drug making the results more significant than they actually appear. Furthermore some of the control patients who improved while in hospital did not hold up their improvement once discharged. An extreme example of this was one psychotically depressed man who appeared to improve and actually seemed to function much better at least while he was in the hospital environment. He was allowed out on leave during which time he committed suicide by jumping off the Lions Gate Bridge. All patients were also rated according to the degree of improvement shown. Maximum represents a complete remission, moderate a substantial improvement by which the patient was able to function quite adequately out of hospital but with continuing minimal disability, and minimum in which only little relief of symptoms was obtained. Of the drug treated patients 12 showed a maximum improvement, 9 moderate, and 3 minimum improvement. The placebo patients who improved showed the same general distribution through the three grades.
Results

By referring to
The total group of patients was also divided according to psychotic or neurotic degree of depression according to the following criteria:
(1) Severity and degree of depression. (2) The degree to which the illness affected the total personality and resulted in divorcement from reality. Table II reports these results and it can be seen that out of 16 patients with Psychotic Depression treated with the drug 11 showed improvement. Out of 22 patients classified as Neurotic Depression treated with the drug 13 showed improvement. Although not of sufficient numbers to be statistically significant there would appear to be a slightly greater percentage of improvement amongst the Psychotic Depressions than amongst the Neurotic Depressions. Other impressions noted by the authors were that those patients who were greatly agitated did rather poorly. However we did not combine the use of the drug with any other such as ataractics so this factor might be controlled by their concomitant use. We also gained the distinct impression that where there was a large reactive element the results tended to be poor. This is as might be expected, that unless the patients were able to deal adequately with their external situation or it could be changed in some other way that results of treatment merely by drug alone were poor. On the other hand in some cases not included in the study the drug did seem to be an adjunct to psychotherapy. It was noted that patients felt capable of tackling their situation and that they were able to do this more objectively.
In order to check the proposed E.C.T. sparing effect of the drug those patients who showed minimal improvement and required electric shock or those patients who were unimproved and were subsequently treated in this way were checked to ascertain the number of treatments required to bring about a substantial improvement in their symptoms. There were ten patients who were on the drug and following the experiment received E.C.T. In all they received a total of 90 electric shocks with an average of 9. Seven patients on placebo received electric shock following this experiment and they were given a total of 98 shocks averaging 14 per person. The median for the drug group was 8 Yz and for the placebo group 10. This is probably an indication of a minimal sparing effect, but we cannot say anymore at the present time. In spite of these findings which are only suggestive we did note as did others, particularly Lehmann, that some patients did show a remarkable response when put on E.C.T. following the drug.
Regarding the Tapping and Dotting, Word Association and Digit Symbol Tests, in each of these there was greater improvement in the drug group than in the controls but none of the average improvements approached statistical significance. We used a "t" test in our analysis of results. On the Wittenborn Psychiatric Rating Scale we tested for only two clusters of symptoms, the one purported to measure anxiety, and the one measuring depression. We also took into consideration the total score for all clusters which we believe would give some indication of a degree of unusual behaviour. All of these measures, anxiety, depression, and total score show average greater increase to normal behaviour for the drug group over the placebo group but the difference between the two groups did not approach statistical significance.
Side Effects and Complications
No serious complications were noted during the study or have been observed by the authors in the use of this drug with many other patients. After the first while we discontinued the practice of taking routine blood pressures but syncope and hypotension were not noted except in one elderly patient. Epilepsy was also not observed. It should be noted that the age group of our patients was perhaps younger than others which reported the presence of hypotensive reaction. W edid not see any addiction in terms of undue dependency or of withdrawal symptoms. However, some patients did relapse following withdrawal of the drug at the end of one month. The majority but not aH of these responded after the drug was reinstituted. The most common minor complication noted was that of sweating. This occurred quite frequently but tended to subside after the medication had been continued for a few days without necessarily reducing it. Tremors were also noted as was constipation. Blood work was not done but there were no serious ill effects in this area. On the whole complications or side effects were not an issue and the drug appeared to be relatively non-toxic. It seems to the authors that side effects generally are regarded as less serious when the patient is in hospital than when he is on an outpatient basis. This may be due to the better control of the patient, more support from the hospital regime and personnel, and perhaps less direct responsibility of the physician to his patient. Summary and Conclusions (1) 62 Depressed patients were observed in a double blind study.
(2) There was a 60% general improvement in the drug treated group.
Comparison of the drug and control group by clinical evaluation was significant at the 1% level of confidence. (3) The differences between a small number (35) of drug and control patients were not significant in the psychological tests employed. (4) The drug may have some E.C.T. sparing effect. (5) No serious complications or side effects were encountered.
